Celentyx at ELRIG 2026

​Celentyx was pleased to take part in ELRIG Drug Discovery 2026, held on 14–15 October at ExCeL London.

​Dr Omar Qureshi at ELRIG Drug Discovery 2026

---

Our Chief Scientific Officer, Dr Omar Qureshi, presented our work on human microglial models and their applications in translational neuroinflammation drug discovery.

Microglia play a central role in neuroinflammation, making human-relevant models valuable tools for investigating disease mechanisms and supporting the development of new therapeutics.

The conference brought together researchers from across the drug discovery community, providing an opportunity to share our work and discuss the role of human microglial models in advancing neuroinflammation research.